JOHN HOWARD: Open Payments
NPI 1205090065 · NILES, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,270 in 53 payments from 20 companies in 2025. Trend: 2023 $1,121 · 2024 $1,127 · 2025 $1,270
Food & beverage: $1,270
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $331 |
| Astellas Pharma US Inc | 4 | $83 |
| ABBVIE INC. | 4 | $83 |
| Novo Nordisk Inc | 4 | $80 |
| Dexcom, Inc. | 3 | $79 |
| Merck Sharp & Dohme LLC | 3 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65 |
| Abbott Laboratories | 3 | $60 |
| Radius Health, Inc. | 3 | $57 |
Products named: FARXIGA, BREZTRI, Veozah, Dexcom G6 Transmitter, AIRSUPRA, VAXNEUVANCE, CAPLYTA, JARDIANCE.
Industry payments across MI — which companies pay providers there.
